| The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse MH James, JE Fragale, SL O'Connor, BA Zimmer, G Aston-Jones Neuropharmacology 183, 108359, 2021 | 24 | 2021 |
| Orexin-1 receptor signaling in ventral tegmental area mediates cue-driven demand for cocaine CB Pantazis, MH James, S O’Connor, N Shin, G Aston-Jones Neuropsychopharmacology 47 (3), 741-751, 2022 | 19 | 2022 |
| The sensation seeking trait confers a dormant susceptibility to addiction that is revealed by intermittent cocaine self-administration in rats SL O'Connor, G Aston-Jones, MH James Neuropharmacology 195, 108566, 2021 | 13 | 2021 |
| The dual orexin/hypocretin receptor antagonist suvorexant reduces addiction-like behaviors for the opioid fentanyl SL O’Connor, JE Fragale, MH James, G Aston-Jones BioRxiv, 2020.04. 25.061887, 2020 | 9 | 2020 |
| The cognitive basis of intracranial self-stimulation of midbrain dopamine neurons SJ Millard, IB Hoang, Z Greer, SL O’Connor, KM Wassum, MH James, ... BioRxiv, 2022.08. 11.503670, 2022 | 4 | 2022 |
| Novelty preference does not predict trait cocaine behaviors in male rats SL O'Connor, G Aston-Jones, MH James Addiction neuroscience 2, 100013, 2022 | 2 | 2022 |
| Machine learning models to predict ligand binding affinity for the orexin 1 receptor VY Zhang, SL O’Connor, WJ Welsh, MH James Artificial Intelligence Chemistry 2 (1), 100040, 2024 | | 2024 |
| Leveraging the orexin system to modulate economic demand for cocaine in male and female rats SL O'Connor Rutgers University-School of Graduate Studies, 2024 | | 2024 |
| The Dual Orexin Receptor Antagonist Suvorexant Reduces Cocaine Motivation and Normalizes Sleep Disturbances During Abstinence U Gyawali, S O'Connor, S Merai, M Paladino, N Krishnakumar, M Bilotti, ... NEUROPSYCHOPHARMACOLOGY 48, 464-465, 2023 | | 2023 |
| The Dual Orexin Receptor Antagonist Suvorexant Reduces Cocaine Behaviors at Non-Sedating Doses in a Rat Model of Addiction SL O'Connor, M Bilotti, M James NEUROPSYCHOPHARMACOLOGY 46 (SUPPL 1), 482-482, 2021 | | 2021 |
| Augmented LH Orexin/Hypocretin Cell Function Underlies the Expression of an Addicted State in Rats M James, C Stopper, B Zimmer, N Koll, H Bowrey, S O'Connor, ... NEUROPSYCHOPHARMACOLOGY 43, S271-S271, 2017 | | 2017 |
Morgan H JamesDept of Psychiatry, Rutgers University, NJ, USAVerified email at rutgers.edu
